Richard M. Wright is SR. VP & CCO of Celldex Therapeutics, Inc.. Currently has a direct ownership of 20,833 shares of CLDX, which is worth approximately $523,741. The most recent transaction as insider was on Jun 03, 2024, when has been sold 46,844 shares (Common Stock) at a price of $33.76 per share, resulting in proceeds of $1,581,453. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.8K
0% 3M change
9915.87% 12M change
Total Value Held $523,741

Richard M. Wright Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2024
SELL
Open market or private sale
$1,581,453 $33.76 p/Share
46,844 Reduced 69.22%
20,833 Common Stock
Jun 03 2024
BUY
Exercise of conversion of derivative security
$1,197,574 $17.75 p/Share
67,469 Added 49.92%
67,677 Common Stock
Aug 15 2022
SELL
Open market or private sale
$578,019 $37.71 p/Share
15,328 Reduced 98.66%
208 Common Stock
Aug 15 2022
BUY
Exercise of conversion of derivative security
$159,105 $10.38 p/Share
15,328 Added 49.66%
15,536 Common Stock
Dec 14 2020
SELL
Open market or private sale
$387,684 $18.61 p/Share
20,832 Reduced 99.01%
208 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$122,909 $5.9 p/Share
20,832 Added 68.49%
9,583 Common Stock
RMW

Richard M. Wright

SR. VP & CCO
Hampton, NJ

Track Institutional and Insider Activities on CLDX

Follow Celldex Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLDX shares.

Notify only if

Insider Trading

Get notified when an Celldex Therapeutics, Inc. insider buys or sells CLDX shares.

Notify only if

News

Receive news related to Celldex Therapeutics, Inc.

Track Activities on CLDX